Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Tags
» Tags
Tags
3D printing
3M
3SBio
21st Century Cures Act
23andMe
89Bio
340B
2016 Presidential election
2020 Presidential election
AACR
Aastrom
Aastrom Biosciences
Abbott
Abbott Laboratories
Abbott Labs
AbbVie
Abecma
Abilify
Abiomed
Ablynx
abortion pill
Abraxane
ABT-450
abuse-resistant painkillers
Acadia
Acadia Pharmaceuticals
ACC
accelerated approvals
Acceleron
Access Pharmaceuticals
Accuray
AcelRx
Achillion
AC Immune
acne
Acorda
Acorda Therapeutics
acquisitions
Actavis
Actelion
Actemra
Acthar
activists
Actos
Acura Pharmaceuticals
acute lymphoblastic leukemia
acute myeloid leukemia
ADA
Adamis Pharmaceuticals
Adaptimmune
Adasuve
Adcetris
ADC Therapeutics
Addyi
ADHD
adolescents
Adolor
aducanumab
Aduhelm
Advair
AdvaMed
Advaxis
Adventrx
adverse events
advisory panel
advisory panels
Aegerion
Aerie Pharma
aesthetics
Aeterna Zentaris
Aethlon Medical
Aetna
Affordable Care Act
Affymax
Affymetrix
Afinitor
Afrezza
Africa
age-related macular degeneration
Agenus
Agios
Agios Pharmaceuticals
agreement
AHA
AIDS
Aimmune
Aimovig
Ajovy
Akorn
Albert Bourla
Alcon
Aldeyra Therapeutics
Alere
Alex Azar
Alex Gorsky
Alexion
Alexion Pharmaceuticals
Alexza
Align Technology
Alimera
Alimta
alirocumab
Alkermes
Allergan
allergies
Allogene
Allos
Almirall
Alnylam
Alphabet
ALS
Alvotech
Alzheimer's disease
Amag Pharmaceuticals
Amarin
Amazon
American Medical Systems
AmerisourceBergen
Amgen
Amicus
Amicus Therapeutics
Amitiza
AML
Amneal
Amphastar
Ampion
Ampio Pharmaceuticals
Ampligen
AMPYRA
AMR101
Amylin
Amylyx
Amylyx Pharmaceuticals
Amyris
Amyvid
Anacetrapib
Anacor
Anadys
analysts
AnaptysBio
Andrew Witty
Androgel
Androxal
anemia
Angeion
AngioDynamics
animal health
ankylosing spondylitis
Anoro Ellipta
Antares
Antares Pharma
Anthem
Anthera
anthrax
anti-aging
anti-clotting
anti-PD-1 immunotherapy
anti-PD-L1
antibiotic resistance
antibiotics
antibodies
antibody-drug conjugate
anticoagulants
antidepressants
antifungals
Antigenics
antihypertensives
antipsychotics
antisense
antitrust
antivirals
anxiety
Apellis Pharmaceuticals
Apixaban
Apotex
AP Pharma
Apple
Apple Watch
approvals
Apricus Biosciences
Aranesp
Arcus Biosciences
Ardea
Ardelyx
Arena
Arena Pharmaceuticals
Argenx
Ariad Pharma
Ariad Pharmaceuticals
Aricept
Arqule
Array Biopharma
Arrowhead Pharmaceuticals
arthritis
ArthroCare
ArtiCure
artificial intelligence
artificial pancreas
Arvinas
Arzerra
ASCO
ASCO 2016
ASCO 2017
ASCO 2018
ASCO 2019
ASCO 2020
ASCO 2021
ASCO 2022
ASCO 2023
ASH 2022
Asia
Aspen Pharmacare
Assembly Biosciences
Astellas
Astex
asthma
AstraZeneca
Athersys
atopic dermatitis
atrial fibrillation
ATTR
Aubagio
Aurinia Pharmaceuticals
Aurobindo
Australia
autism
autoimmune disease
Auxilium
Avanafil
Avandia
Avanir
Avastin
avelumab
Aveo Oncology
Aveo Pharmaceutical
Aveo Pharmaceuticals
AveXis
AVI BioPharma
award
Axovant
AXS-05
Axsome Therapeutics
AZD9291
BACE inhibitors
bacteriophage
BAN2401
bankruptcy
bapineuzumab
BARDA
baricitinib
Barr Laboratories
Basilea
Bausch & Lomb
Bausch Health
Bavarian Nordic
Bavencio
bavituximab
Baxalta
Baxter
Baxter International
Bayer
bb2121
Beam Therapeutics
Becton Dickinson
BeiGene
Bellicum
beloranib
Belviq
bempedoic acid
benign prostatic hyperplasia
Benlysta
Bernie Sanders
beta thalassemia
Bexsero
Bextra
BG-12
Bicycle Therapeutics
Big Data
Big Pharma
Biktarvy
Bill Ackman
Bill Gates
BIO
biobucks
Biocon
Biocryst
Biodel
BioDelivery Sciences
Biogen
Biogen Idec
BiogenIdec
Biohaven
BioLase
biologics
Biomarin
biomarkers
Biomet
BioMimetic Therapeutics
BioNTech
BioSante
biosimilars
biotech
biotech hubs
biotech stocks
BioTime
Biotronik
Biovail
Bioverativ
bipolar disorder
birth control
birth control pill
birth defects
bispecific antibodies
black box
bladder cancer
blockchain
blood
blood cancer
blood cancers
blood clots
blood glucose monitoring
blood thinners
bloodthinners
Bluebird Bio
Blueprint Medicines
Boehringer Ingelheim
bonds
boosters
Boston
Boston Scientific
Botox
Bovie Medical
brain
brain cancer
BrainStorm Cell Therapeutics
branding
Brazil
breakthrough status
breakthrough therapies
breakthrough therapy
breast
breast cancer
breast implants
Brent Saunders
Breo Ellipta
Brexit
bribery
BridgeBio
Brilinta
Bristol-Myers Squibb
Bristol Myers Squibb
brodalumab
BSD Medical
buyouts
Bydureon
Byetta
C. difficile
Cabometyx
cabotegravir
cabozantinib
Cadence Pharmaceuticals
cafepharma
California
Canada
cancer
cancer immunotherapy
cancer vaccines
cannabis
Cantel Medical
CAR-T
Cara Therapeutics
Cardiac
Cardica
Cardinal Health
cardiology
Cardiome
Cardiovascular
cardiovascular disease
Cardiovascular Systems
CareFusion
Carfilzomib
Caribou Biosciences
Carl Icahn
Carvykti
Cassava Sciences
Catalent
catheter
catheters
CDC
CDER
CDMO
CDMOs
Cel-Sci
Celebrex
celebrity endorsements
Celgene
celiac disease
Cellceutix
Celldex
Celldex Therapeutics
Cellectis
Cell Therapeutics
cell therapy
Celltrion
Celsion
CE Mark
Cempra
CEO
Cephalon
Cerevel Therapeutics
Cerezyme
Cerus
Cervarix
cervical cancer
CETP inhibitors
CFO
Chantix
Charles River Laboratories
Chelsea Therapeutics
ChemoCentryx
chemotherapy
chemotherapy-induced nausea and vomiting
chicago
chikungunya virus
Chimerix
China
China Medical Technologies
CHMP
cholesterol
Chris Viehbacher
chronic cough
chronic kidney disease
chronic lymphocytic leukemia
chronic myeloid leukemia
chronic pain
Chugai
Cialis
Cigna
Cinryze
Cipla
Class Action Lawsuit
Clinical Data
clinical depression
clinical hold
clinical trial
clinical trial data
clinical trial diversity
clinical trials
CLL
Clostridium Difficile
Clovis Oncology
CML
CMOs
CMS
CMV
CNS
Coherus Biosciences
Cologuard
colon cancer
colorectal cancer
companies
compassionate use guidelines
competition
Complete Genomics
complete response letter
CompuGen
Conceptus
Concerta
Concert Pharmaceuticals
congress
Conmed
consumer health
consumers
continuous glucose monitoring
contraceptives
contract
Contrave
Cook Medical
Copaxone
COPD
Corcept Therapeutics
Cordis
CoreValve
Cornerstone Therapeutics
coronavirus
coronaviruses
Cosentyx
Cougar Biotechnology
COVID-19
COVID-19 variants
Covidien
CR Bard
Crestor
CRISPR
CRISPR Therapeutics
Crohn's Disease
Crohn’s disease
CROs
Crucell
Cryolife
CSL
CTI BioPharma
CTL019
Cubicin
Cubist
Cubist Pharma
Cubist Pharmaceuticals
Cumberland
CureVac
Curis
Cutera
CVS
CVS Health
CV Therapeutics
cyberattacks
Cyberknife
Cyberonics
cybersecurity
Cyclacel
Cymbalta
Cynosure
Cypress Bioscience
Cyramza
cystic fibrosis
Cytokinetics
CytomX
Cytori
CytRx
daclatasvir
Daiichi Sankyo
Daniel Vasella
Dapagliflozin
Daraprim
daratumumab
Darzalex
data
David Ricks
Daxas
DBV Technologies
DEA
debt
decentralized clinical trials
defibrillators
Delcath
Delta COVID-19 variant
dementia
Denali Therapeutics
Dendreon
dengue
denosumab
dental
Dentsply
Depakote
Department of Defense
Depomed
depression
DePuy
DePuy Synthes
Derma Sciences
dermatology
development
Device
device manufacturing
device recalls
device reps
devices
device tax
DexCom
diabetes
diabetic macular edema
diabetic neuropathy
diabetic retinopathy
diagnostics
dialysis
diffuse large B-cell lymphoma
digital health
digital marketing
digital pharma
digital therapeutics
dimebon
Diovan
Discovery Labs
discrimination
distribution
diversity
dividends
DMD
DNA
DNA sequencing
DOJ
Dolutegravir
Donald Trump
donanemab
Doxil
Dravet syndrome
drisapersen
Dr Reddy's
Drug
drug-device combos
drug ads
drug approvals
drug delivery
drug development
drug discounts
drug discovery
drug importation
drug launches
drug manufacturing
drug marketing
drug names
drug prices
drug pricing
drug rebates
drug reps
drug safety
drug sales
drug shortages
drug spending
drug stocks
drug trials
dry eye disease
DTC
DTC ads
DTC advertising
Duchenne Muscular Dystrophy
dulaglutide
dupilumab
Dupixent
Durect Corporation
Dyax
Dynavax
Dynavax Technologies
earnings
ebola virus
Echo Therapeutics
eczema
Editas Medicine
Edwards Lifesciences
Effient
EHA
EHRs
Eisai
Elagolix
Elan
Elanco
elderly
Eli Lilly
Eliquis
Elizabeth Holmes
Elon Musk
EMA
Emergency Use Authorization
Emergent BioSolutions
emerging markets
Emgality
Emma Walmsley
employees
Enanta Pharmaceuticals
Enbrel
Endo
Endocyte
Endo Health Solutions
Endo International
Endologix
endometrial cancer
endometriosis
Enhertu
Enterome
EnteroMedics
EntreMed
Entresto
environmental concerns
Enzon
Epidiolex
epilepsy
EpiPen
EpiPens
Epizyme
Epogen
Erbitux
erectile dysfunction
Esbriet
esketamine
ESMO
esophageal cancer
Esperion Therapeutics
Essure
eteplirsen
Ethicon
etrasimod
EU
Europe
European
evolocumab
Evotec
exa-cel
EXACT Sciences
exclusivity
executive compensation
executive pay
executives
Exelixis
Exondys 51
expansion
EXPAREL
Express Scripts
Exscientia
eye
eye disease
eye health
Eylea
Fabrazyme
Fabry's disease
Fabry disease
Facebook
Facet Biotech
False Claims Act
Fanapt
Farxiga
Fasenra
fast track
FCPA
FDA
federal government
female sexual dysfunction
FibroGen
fibromyalgia
filgotinib
financing
Finch Therapeutics
Five Prime
Flagship Pioneering
Flexion
Florida
Flu
flu vaccine
flu vaccines
follicular lymphoma
food allergies
Forest Labs
formulary
Forty Seven
Fosamax
Foundation Medicine
France
fraud
free speech
Fresenius
FTC
Fujifilm
funding
Fusilev
Galapagos
Galderma
Galena Biopharma
Gamida Cell
gantenerumab
Gardasil
gastric cancer
Gates Foundation
Gattex
Gaucher disease
Gazyva
GE
GE Healthcare
gender discrimination
gene editing
Genentech
generics
gene sequencing
gene therapy
genetics
genetic testing
Genfit
Genmab
genomics
Gentium
GenVec
Genzyme
geographic atrophy
George Scangos
Germany
Geron
GI Dynamics
Gilead
Gilead Sciences
Gilenya
Ginkgo Bioworks
Giovanni Caforio
Given Imaging
glaucoma
Gleevec
Glenmark
glioblastoma
glioblastoma multiforme
Global Blood Therapeutics
Globus Medical
GLP-1 agonist
Google
Gossamer Bio
gout
government
government contracts
government shutdown
GPO
graft vs host disease
Grail
grants
Greatbatch
Grifols
GS-7977
GSK
GTx
Guardant Health
guidance
Guidant
Guided Therapeutics
GW Pharma
H.P. Acthar Gel
H1N1
hacking
HAE
Haemonetics
Halozyme
Hansen Medical
Harpoon Therapeutics
Harvard
Harvoni
Hatch Waxman Act
HCV
head and neck cancer
headquarters
Healthcare
healthcare bill
Healthcare on the Hill
healthcare reform
hearing loss
heart
heart attack
heart attacks
heart disease
heart failure
heart valve
heart valves
HeartWare
Hemispherx
Hemispherx Biopharma
Hemlibra
hemophilia
hemophilia A
hemophilia B
Henri Termeer
hepatitis
hepatitis B
hepatitis C
hepatocellular carcinoma
Heplisav
Herceptin
hereditary angiodema
Heron Therapeutics
HHS
Hikma
Hill-Rom
Hillary Clinton
hip
hip implants
hip replacements
hirings
HIV
Hodgkin's lymphoma
Hologic
Homozygous Familial Hypercholesterolemia
Hong Kong
Horizant
Horizon Pharma
Horizon Therapeutics
Hospira
Hospital
hospitals
hostile bid
hot flashes
HPV
HRT
Humalog
Humana
Human Genome Sciences
Humira
Huntington's disease
hydrocodone
hydroxychloroquine
hypercholesterolemia
hypertension
Ian Read
IBD
IBM
Ibrance
ibrutinib
IBS
IBS-C
Icagen
ICD
ICER
Iclusig
ICU Medical
Idenix
Idera Pharmaceuticals
idiopathic pulmonary fibrosis
Idorsia
Illumina
Iluvien
imaging
Imbruvica
imetelstat
Imfinzi
immuno-oncology
ImmunoCellular
ImmunoCellular Therapeutics
Immunocore
Immunogen
immunology
Immunomedics
immunotherapy
Impax
Impax Laboratories
Impax Labs
Impella
Implant
implants
Incivek
inclisiran
incubators
Incyte
Indenix
India
Indivior
industry
infant formula
infectious diseases
Infinity Pharmaceuticals
inflammation
inflammatory bowel disease
inflation
Inflation Reduction Act
Inflectra
influenza
inhaled insulin
inhalers
Inhibitex
injectables
innovation
Innovent Biologics
Inovio
insider trading
Insmed
insomnia
Inspire
Insulet
insulin
insulin pumps
insurance
insurers
Insys
INSYS Therapeutics
Intarcia
Integra LifeSciences
intellectual property
Intellia Therapeutics
Intercept Pharma
Intercept Pharmaceuticals
Intermezzo
InterMune
international
Intra-Cellular Therapies
Intrexon
Intuitive Surgical
Invacare
investigation
investment
investors
Invivo Therapeutics
Invokana
Ionis Pharmaceuticals
IPF
iPhone
ipilimumab
IPO
IPOs
Ipsen
IQVIA
Ireland
Ironwood
Ironwood Pharmaceuticals
irritable bowel syndrome
IRS
Isis Pharmaceuticals
IsoRay
Israel
Ista
Italy
J&J
J. Michael Pearson
Jakafi
JAK inhibitors
JAMA
Janet Woodcock
Janssen
Janssen Biotech
Janumet
Januvia
Japan
Jardiance
Javelin
Jazz Pharma
Jazz Pharmaceuticals
Jeff Kindler
JNJ
job cuts
jobs
Joe Biden
Joe Jimenez
John Lechleiter
Johnson & Johnson
Joseph Papa
Jounce Therapeutics
JPMHC 2017
JPMHC 2018
JPMHC 2019
JPMHC 2020
JPMHC 2021
JPMHC 2022
JPMHC 2023
JPMHC 2024
JPMorgan
Juno Therapeutics
Kadcyla
Kaleido Biosciences
Kaleo
KaloBios
Kalydeco
Karuna Therapeutics
KarXT
Karyopharm
KCI
Ken Frazier
Kenneth Frazier
Kensey Nash
Kentucky
Keryx
Kevzara
Keytruda
kickbacks
kidney cancer
kidney disease
Kinetic Concepts
King
Kisqali
Kite Pharma
knee
Korea
KRAS
KRAS inhibitors
Krystal Biotech
Krystexxa
KTE-C19
KV Pharmaceutical
Kymriah
Kynamro
Kyprolis
Kåre Schultz
LabCorp
labeling
La Jolla Pharmaceutical
Lannett
Lantus
laquinimod
laser
lasers
launch
law
lawsuit
lawsuits
layoffs
LCZ696
lebrikizumab
lecanemab
legal
Legend Biotech
legislation
Lemtrada
LentiGlobin
Lenvima
LEO Pharma
Leqembi
leukemia
Levadex
Levaquin
Lexapro
Lexicon Pharmaceuticals
LibiGel
Libtayo
licensing
life sciences
Life Technologies
Ligand
Ligand Pharmaceuticals
Linzess
Lipitor
liquid biopsy
liraglutide
liso-cel
liver cancer
liver disease
lobbying
logistics
Long COVID
Lonza
lorcaserin
Lou Gehrig's disease
Lovenox
Loxo Oncology
Lpath
Lucentis
Lumakras
Luminex
Lundbeck
lung cancer
Lupin
lupus
Luxturna
Lyme disease
lymphoma
Lymphoseek
Lynparza
Lyrica
M&A
machine learning
Macrogenics
macular degeneration
Madrigal Pharmaceuticals
Magenta Therapeutics
major depressive disorder
Makena
Mako Surgical
malaria
Mallinckrodt
Management
MannKind
mantle cell lymphoma
manufacturing
MAP Pharmaceuticals
marijuana
market
marketing
Martin Shkreli
Maryland
Masimo
Massachusetts
McKesson
MDS
MDV3100
Mead Johnson
med-tech
Meda
Medarex
Medicaid
Medical Device
medical devices
medical device tax
Medical Marijuana
medical supplies
Medicare
Medicare Part D
Medicines Company
Medicis
MedImmune
Medivation
Medivir
Medtech
Medtronic
medullary thyroid cancer
Mekinist
melanoma
MELA Sciences
meningitis
menopause
Merck
Merck KGaA
Merck Serono
Merrimack Pharmaceuticals
Mesoblast
mesothelioma
metastatic breast cancer
metastatic castration-resistant prostate cancer
metastatic melanoma
metastatic non-small cell lung cancer
metformin
Mexico
microbiome
Micromet
Microsoft
mifepristone
migraines
Milestone
Miles White
Millennium
MiMedx
Mindray
Minnesota
mipomersen
Mirati Therapeutics
mirikizumab
Misonix
MIT
MK-3475
MM-398
mobile
mobile apps
Moderna Therapeutics
molnupiravir
Momenta
Momenta Pharmaceuticals
monitoring
monkeypox
monoclonal antibodies
MorphoSys
Mounjaro
MRI
MRNA
mRNA-1273
MRSA
MS
Multaq
Multikine
Multiple Myeloma
multiple sclerosis
MultiStem
muscular dystrophy
myasthenia gravis
myelodysplastic syndrome
myelofibrosis
Mylan
Mylan Labs
MyoKardia
Myriad
Myriad Genetics
Namenda
Namenda XR
Nanosphere
narcolepsy
NASDAQ
NASH
Navidea Biopharmaceuticals
NDA
Nektar
Nektar Therapeutics
Neoprobe
NeoStem
neratinib
Nestle
Neulasta
Neupogen
Neuralstem
Neurocrine
Neurocrine Biosciences
neurodegenerative disease
NeurogesX
neurology
NeuroMetrix
Neurontin
Neuroscience
neurostimulation
NeuVax
New Jersey
NewLink Genetics
New York
Nexavar
Nexium
NGM Biopharmaceuticals
NHS
Niaspan
NICE
NIH
nivolumab
NKTR-214
non-Hodgkin's lymphoma
non-opioid pain treatments
non-small cell lung cancer
North Carolina
Northera
Northwest Biotherapeutics
Novartis
Novavax
Novocure
Novo Nordisk
NPS Pharmaceuticals
Nucala
Nuedexta
NuPathe
Nuplazid
NurOwn
NuVasive
NUVIGIL
NxStage Medical
Nycomed
Obagi Medical Products
Obama
Obamacare
obesity
obeticholic acid
OCA
Ocaliva
ocrelizumab
Ocrevus
Ocular Therapeutix
Oculus Innovative Sciences
off-label
Ofirmev
Ohio
Olivier Brandicourt
olumiant
Olympus
Olysio
Omecamtiv Mecarbil
Omeros
Omicron COVID-19 variant
OncoGenex
oncologists
oncology
Oncolytics
OncoMed
OncoSec
Oncothyreon
Onglyza
Onpattro
Onyx
ONYX Pharmaceuticals
Opana ER
Opdivo
OPDP
Operation Warp Speed
Opexa
ophthalmology
Ophthotech
opiods
opioid addiction
opioid crisis
opioids
OPKO Health
Optimer
Optimer Pharmaceuticals
options
OraSure
Orencia
Orexigen
Organon
Organovo
Orkambi
orphan drugs
Orthofix
orthopaedics
Orthopedics
Orthovita
OSI Pharmaceuticals
Osiris
Osiris Therapeutics
osteoarthritis
osteoarthritis of the knee
osteoporosis
OTC
Otezla
Otsuka
ovarian cancer
overactive bladder
overtime lawsuits
Ovid Therapeutics
Oxford BioMedica
Oxigene
oxycontin
ozanimod
Ozempic
P&G
pacemakers
Pacific Biosciences
Pacira
Padcev
PAH
painkillers
pain management
Pain Therapeutics
palbociclib
pancreatic cancer
pandemic
Paratek
Parkinson's Disease
Parkinson's Disease Psychosis
Par Pharmaceutical
PARP inhibitors
partnerships
Pascal Soriot
patent
patent cliff
Patent Infringement
patents
patient
patient deaths
patients
Patisiran
Paul Hudson
Paxil
Paxlovid
pay-for-delay
payers
PBMs
PCSK9 inhibitors
PDL Biopharma
PDUFA
peanut allergy
Pear Therapeutics
pediatric
pediatrics
pelvic mesh
Pennsylvania
peramivir
Peregrine Pharmaceuticals
perifosine
Perjeta
PerkinElmer
Perrigo
Perrigo Company
personalized medicine
Pfizer
pharma advertising
Pharma CEOs
pharmacies
Pharmacyclics
pharma industry
pharma marketing
Pharmasset
pharma stocks
PharmAthene
philanthropy
Philidor Rx
Philips
PhRMA
physician access
physician gifts
physician payments
Physician Payment Sunshine Act
physicians
pimavanserin
Pinnacle Hip
pipelines
Piramal Healthcare
pixantrone
PKU
Plan B contraceptive
Plavix
plecanatide
Pluristem
Pluristem Therapeutics
PMA
PML
pneumococcal disease
pneumonia
PNH
politics
Pomalyst
Pompe disease
Portola Pharmaceuticals
postpartum depression
Pozen
Pradaxa
Praluent
Precision Biosciences
precision medicine
pregnancy
Premier
Prempro
PrEP
prescription data
Prevnar
Prevnar 13
price fixing
priority review
priority review vouchers
Probuphine
Proctor & Gamble
product recalls
profits
Progenics
Progenics Pharmaceuticals
Prolia
Prolor
Prosensa
prostate cancer
Protalix BioTherapeutics
protein degradation
Prothena
Provenge
Provention Bio
Provigil
pSivida
psoriasis
psoriatic arthritis
PTC Therapeutics
PTSD
Public Citizen
Public Health
Puerto Rico
pulmonary arterial hypertension
Puma Biotechnology
Purdue
Purdue Pharma
Qiagen
QLT
Qnexa
Qsymia
Quad
Questcor
Questcor Pharmaceuticals
Quest Diagnostics
R&D
radiation
Radient Pharmaceuticals
Radiology
radiopharmaceuticals
radiotherapy
Radius Health
Ranbaxy
Raptor Pharmaceuticals
rare disease
Rare Diseases
Ratiopharm
real world data
real world evidence
Reata Pharmaceuticals
rebates
recall
recalls
Receptos
Reckitt Benckiser
regenerative medicine
Regeneron
Regenxbio
regorafenib
regulatory
Regulus
reimbursement
Relistor
Relypsa
remdesivir
Remicade
Remoxy
renal cell carcinoma
renal denervation
reorganization
Repatha
Repligen
Repros Therapeutics
reputation
research
ResMed
Respiratory
Restasis
restless legs syndrome
restructuring
Retrophin
Revance Therapeutics
revenues
Revlimid
Rexahn
rheumatoid arthritis
Rhythm Pharmaceuticals
Riata
Richard Gonzalez
ridaforolimus
Rigel
Rigel Pharmaceuticals
right-to-try laws
Rinvoq
risdiplam
Risperdal
Rituxan
RNA
RNAi
Robert Califf
robotics
robotic surgery
Roche
rociletinib
Rockwell Medical
Roivant
romosozumab
Rova-T
roxadustat
Royalty Pharma
RSV
Rubraca
Russia
ruxolitinib
RWE
RXi Pharmaceuticals
Sackler family
safety
SAGE Therapeutics
salaries
sales
sales reps
Salix
samples
Samsung Bioepis
Samsung BioLogics
Sandoz
San Francisco
Sangamo BioSciences
Sangamo Therapeutics
Sanofi
Sanofi Genzyme
Sanofi Pasteur
Santarus
Sanuwave
Sapien
sarcoma
Sarepta
Sarepta Therapeutics
Savient
Saxenda
Schering Plough
schizophrenia
SciClone
Scott Gottlieb
Seagen
Seattle Genetics
SEC
securities fraud
semaglutide
Senate
Sepracor
Sequenom
Seres Therapeutics
Seroquel
Servier
settlements
severe asthma
Severin Schwan
SGLT2 inhibitor
shareholders
share repurchase
shingles
Shingrix
Shionogi
Shire
short bowel syndrome
sickle cell disease
side effects
Siemens
SIGA technologies
Silenor
Simcere
Simponi
Singapore
Singulair
Sinovac
Sirona Dental
skin cancer
Skyrizi
sleep apnea
SMA
small cell lung cancer
small molecule drugs
Smith & Nephew
smoking cessation
Sobi
social media
sofosbuvir
software
solanezumab
Solid Biosciences
solid tumors
Soliris
Solithromycin
Solta Medical
Solvay
Somaxon
SonoSite
Sorrento Therapeutics
South Africa
South Korea
Sovaldi
SPAC
SPACs
Spain
Spark Therapeutics
Spectranetics
Spectrum Pharmaceuticals
Spinal
spinal muscular atrophy
Spine
spinoff
spinoffs
Spinraza
Sprout Pharmaceuticals
Sprycel
SRP-9001
St. Jude Medical
Stada
start-ups
startups
statins
Stelara
StemCells
stem cells
Stendra
stent
stents
Stephane Bancel
Stephen Hahn
Stereotaxis
Steris
Stimuvax
stock
stock buyback
stock offering
stocks
stomach cancer
Strides Arcolab
stroke
Stryker
Suboxone
Subsys
Sucampo
suicide
Sunesis
Sunovion
Sun Pharma
superbugs
Supergen
Supernus Pharmaceuticals
supply
supply chain
Supreme Court
Surfaxin
surgery
surgical
sustainability
Sutent
suvorexant
Sweden
swine flu
Switzerland
Symbicort
Symmetry Medical
Synergetics
Synergy Pharmaceuticals
Syneron
Syneron Medical
Synlogic
Synta
Synta Pharmaceuticals
Synthes
T-DM1
tafamidis
Tafinlar
Tagrisso
Takeda
talazoparib
Talecris
Taltz
Tamiflu
Tandem Diabetes
tanezumab
Tarceva
tardive dyskinesia
Targacept
Taro
Tasigna
TAVR
tax
taxes
tax inversions
tax reform
Tecentriq
Tecfidera
tech
technology
Tekmira Pharmaceuticals
Telaprevir
Teleflex Medical
telehealth
telemedicine
television ads
Tesaro
testosterone
Tetraphase Pharmaceuticals
Teva
Teva Pharmaceutical
Teva Pharmaceuticals
Texas
TG Therapeutics
TH-302
The Cooper Companies
The Medicines Company
Theragenics
Theranos
therapy
Theravance
ThermoDox
Thermo Fisher
Thermogenesis
Thoratec
Threshold Pharmaceuticals
thyroid cancer
thyroid eye disease
tiragolumab
tirzepatide
Titan
Titan Pharmaceuticals
tivozanib
tofacitinib
TomoTherapy
Topamax
Toujeo
trade secrets
training
Transcept
Translate Bio
transparency
treatment
Tredaptive
tremelimumab
Tremfya
Tresiba
Trimeris
triple negative breast cancer
Trius Therapeutics
Trodelvy
TrueBeam
Trulicity
Truvada
tuberculosis
Turing Pharmaceuticals
Turning Point Therapeutics
twitter
Tykerb
Tylenol
type 1 diabetes
type 2 diabetes
Tysabri
UCB Pharma
UCB Pharmaceuticals
UK
Ukraine
ulcerative colitis
Ultomiris
Ultragenyx
ultrasound
Unilife
uniQure
Unitedhealth Group
United States
United Therapeutics
University of Oxford
Upadacitinib
upgrades
Upjohn
urothelial cancer
US
US Congress
user fees
uterine fibroids
UTIs
vaccine
vaccines
Valeant Pharmaceuticals
Valneva
Vanda
Vanda Pharmaceuticals
Varian
Varian Medical
Vascepa
vascular
Vascular Solutions
Vas Narasimhan
Vaxart
Vectibix
Vectura
Vedanta Biosciences
Veklury
Velcade
Venclexta
ventilators
venture capital
Verastem
Verily
Versant Ventures
Vertex
Vertex Pharmaceuticals
Verve Therapeutics
Verzenio
veterinary medicine
Viagra
Viaskin Peanut
Viatris
Vical
Victoza
Victrelis
Viekira Pak
ViiV
ViiV Healthcare
Viking Systems
Viking Therapeutics
vintafolide
Vioxx
Vir Biotechnology
ViroPharma
Vivek Ramaswamy
Vivus
Volcano Corporation
Vorapaxar
Voyager Therapeutics
Vyndaqel
Vytorin
Vyvanse
Walgreens
Walgreens Boots Alliance
Walmart
Warfarin
Warner Chilcott
warnings
Warren Buffett
Watson
Watson Pharmaceuticals
Wave Life Sciences
wearables
Wegovy
weight loss
wet age-related macular degeneration
whistleblower lawsuits
whistleblowers
White House
WHO
William Weldon
women
Women's Health
women executives
wound care
Wright Medical
Wuhan Coronavirus
WuXi PharmaTech
Wyeth
Xalkori
Xarelto
Xeljanz
Xencor
XenoPort
Xgeva
Xiaflex
Xifaxan
Xiidra
Xolair
Xoma
Xtandi
Xyrem
Yaz
Yervoy
Yescarta
YM BioSciences
Zafgen
Zalicus
Zaltrap
Zantac
Zarxio
Zealand Pharma
Zejula
Zelboraf
Zeltiq
Zepatier
Zepbound
Zerenex
Zetia
Zevalin
Zika virus
Zimmer
Zimmer Biomet
Ziopharm
Zoetis
Zogenix
Zohydro
Zohydro ER
Zolgensma
ZOLL Medical
Zoloft
Zometa
Zostavax
zuranolone
Zymeworks
ZymoGenetics
Zynteglo
Zyprexa
Zytiga